<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor</title>
			</titleStmt>
			<publicationStmt>
				<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
				<availability status="unknown"><p>Copyright American Society for Biochemistry &amp; Molecular Biology (ASBMB)</p>
				</availability>
				<date type="published" when="2009-10-27">October 27, 2009,</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christina</forename><forename type="middle">Rye</forename><surname>Underwood</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Patrick</forename><surname>Garibay</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lotte</forename><forename type="middle">Bjerre</forename><surname>Knudsen</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Diabetes Biology and Pharmacology</orgName>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sven</forename><surname>Hastrup</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Protein Expression, and § § Structure and Biophysical Chemistry</orgName>
								<orgName type="institution">Novo Nordisk</orgName>
								<address>
									<postCode>2760</postCode>
									<settlement>Måløv</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Günther</forename><forename type="middle">H</forename><surname>Peters</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rainer</forename><surname>Rudolph</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">GLP-1 and Obesity Biology, ¶ Protein and Peptide Chemistry</orgName>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department of Chemistry, MEMPHYS Center for Biomembrane Physics</orgName>
								<orgName type="institution">Technical University of Denmark</orgName>
								<address>
									<postCode>2800</postCode>
									<settlement>Kgs. Lyngby</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steffen</forename><surname>Reedtz-Runge</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Chemistry, MEMPHYS Center for Biomembrane Physics</orgName>
								<orgName type="institution">Technical University of Denmark</orgName>
								<address>
									<postCode>2800</postCode>
									<settlement>Kgs. Lyngby</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="department">‡ ‡ Institute for Biochemistry and Biotechnology</orgName>
								<orgName type="institution">Martin Luther University Halle</orgName>
								<address>
									<postCode>06120</postCode>
									<settlement>Wittenberg, Halle</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Novo Nordisk Park</orgName>
								<address>
									<addrLine>G8.S.439, DK</addrLine>
									<postCode>2760</postCode>
									<settlement>Måløv</settlement>
									<country key="DK">Denmark</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Journal of Biological Chemistry</title>
						<title level="j" type="abbrev">J. Biol. Chem.</title>
						<idno type="ISSN">0021-9258</idno>
						<idno type="eISSN">1083-351X</idno>
						<imprint>
							<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
							<biblScope unit="volume">285</biblScope>
							<biblScope unit="issue">1</biblScope>
							<biblScope unit="page" from="723" to="730"/>
							<date type="published" when="2009-10-27">October 27, 2009,</date>
						</imprint>
					</monogr>
					<idno type="DOI">10.1074/jbc.m109.033829</idno>
					<idno type="PMID">19861722</idno>
					<idno type="PMCID">PMC2804221</idno>
					<ptr type="open-access" target="http://www.jbc.org/content/285/1/723.full.pdf" />
					<note type="submission">Received for publication, June 17, 2009, and in revised form, September 21, 2009</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:29+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>GLP-1 (glucagon-like peptide-1) is an incretin released from intestinal L-cells in response to food intake. Activation of the GLP-1 receptor potentiates the synthesis and release of insulin from pancreatic ␤-cells in a glucose-dependent manner. The GLP-1 receptor belongs to class B of the G-protein-coupled receptors, a subfamily characterized by a large N-terminal extracellular ligand binding domain. Exendin-4 and GLP-1 are 50% identical, and exendin-4 is a full agonist with similar affinity and potency for the GLP-1 receptor. We recently solved the crystal structure of the GLP-1 receptor extracellular domain in complex with the competitive antagonist exendin-4(9-39). Interestingly, the isolated extracellular domain binds exendin-4 with much higher affinity than the endogenous agonist GLP-1. Here, we have solved the crystal structure of the extracellular domain in complex with GLP-1 to 2.1 Å resolution. The structure shows that important hydrophobic ligand-receptor interactions are conserved in agonist-and antagonist-bound forms of the extracellular domain, but certain residues in the ligand-binding site adopt a GLP-1-specific conformation. GLP-1 is a kinked but continuous ␣-helix from Thr 13 to Val 33 when bound to the extracellular domain. We supplemented the crystal structure with site-directed mutagenesis to link the structural information of the isolated extracellular domain with the binding properties of the full-length receptor. The data support the existence of differences in the binding modes of GLP-1 and exendin-4 on the full-length GLP-1 receptor.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>GLP-1 (glucagon-like peptide-1) is a peptide hormone produced by post-translational processing of proglucagon in the intestinal L-cells <ref type="bibr" target="#b0">(1)</ref>. GLP-1 is an incretin that potentiates the synthesis and release of insulin from pancreatic ␤-cells in a glucose-dependent manner <ref type="bibr" target="#b1">(2)</ref> and has a number of other beneficial effects that contribute to reducing blood sugar <ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref><ref type="bibr" target="#b5">(6)</ref>. In addition, GLP-1 has been shown to reduce body weight <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b6">7)</ref>, which is favorable for many people with type 2 diabetes. Hence, GLP-1-based therapies are becoming increasingly attractive for the treatment of type 2 diabetes. The actions of GLP-1 are mediated through the GLP-1 receptor (GLP-1R), <ref type="bibr" target="#b2">3</ref> which is a seven-transmembrane G protein-coupled receptor (GPCR) coupled to adenylyl cyclase <ref type="bibr" target="#b7">(8)</ref>. The human GLP-1R was first cloned in 1992 and belongs to class B of GPCRs <ref type="bibr" target="#b8">(9)</ref>. This class includes a wide range of receptors for peptide hormones like glucagon, GLP-2 (glucagon-like peptide-2), glucosedependent insulinotropic polypeptide (GIP), pituitary adenylyl cyclase-activating polypeptide (PACAP), vasoactive intestinal polypeptide, secretin, calcitonin, corticotrophinreleasing factor, and parathyroid hormone (PTH) <ref type="bibr" target="#b9">(10)</ref>. The receptors are distinguished by their large extracellular N-terminal domain (ECD), which is important for ligand binding and selectivity <ref type="bibr" target="#b10">(11,</ref><ref type="bibr" target="#b11">12)</ref>. The current binding model suggests a two-domain mechanism where the C-terminal part of the ligand binds the ECD and the N-terminal part of the ligand binds the extracellular loops and transmembrane ␣-helices (TM domain), which leads to receptor activation (reviewed in Ref. <ref type="bibr" target="#b12">13</ref>).</p><p>The first structure of an isolated ECD of a class B GPCR was solved recently by NMR spectroscopy <ref type="bibr" target="#b13">(14)</ref>. Subsequently, structures of ligand-bound ECDs were solved, including the ECD of the human type 1 corticotrophin-releasing factor receptor 1 <ref type="bibr" target="#b14">(15)</ref>, the human type 1 PACAP receptor <ref type="bibr" target="#b15">(16)</ref>, the human GIP receptor <ref type="bibr" target="#b16">(17)</ref>, the human GLP-1R <ref type="bibr" target="#b17">(18)</ref>, and the human type 1 PTH receptor <ref type="bibr" target="#b18">(19)</ref>. The ECDs of class B receptors have a common structure, the secretin recognition fold, which is stabilized by three conserved disulfide bonds and five conserved residues (Asp 67 , Trp 72 , Pro 86 , Gly 108 , and Trp 110 in GLP-1R). The receptor-bound ligands are primarily in ␣-helical con-formation, and the C-terminal part of the ligands binds the ECD in agreement with the two-domain binding mechanism. Several receptor models have been proposed for full-length class B receptors <ref type="bibr">(20 -23)</ref>. However, the orientation of the ECD relative to the TM domain is uncertain.</p><p>Exendin-4 is a 39-amino acid peptide, which was originally isolated from the venom of the lizard Heloderma suspectum <ref type="bibr" target="#b23">(24)</ref>. GLP-1 and exendin-4 are 50% identical, and exendin-4 is a full agonist with similar affinity and potency for the full-length GLP-1R <ref type="bibr" target="#b24">(25)</ref>. However, structure-activity studies have demonstrated interesting differences between the binding modes of GLP-1 and exendin-4. 1) The isolated ECD binds exendin-4 with high affinity (IC 50 of 6 nM) and GLP-1 with low affinity (IC 50 Ͼ500 nM) <ref type="bibr" target="#b25">(26,</ref><ref type="bibr" target="#b26">27)</ref>. 2) GLP-1 binding is more sensitive to site-directed mutagenesis of the TM domain compared with exendin-4 binding <ref type="bibr">(28 -30)</ref>. 3) GLP-1 is much more sensitive to N-terminal truncation than exendin-4 <ref type="bibr" target="#b30">(31)</ref>. N-terminally truncated exendin-4 variants maintain high affinity but are unable to activate GLP-1R, i.e. competitive antagonist, whereas N-terminal truncation of GLP-1 severely affects both binding and activation <ref type="bibr" target="#b30">(31)</ref>. Clearly, the interaction between the N-terminal part of GLP-1 and the TM domain is critical for binding and activation of GLP-1R.</p><p>Exendin-4(9 -39) is a truncated form of exendin-4, and a competitive antagonist that maintains high affinity for GLP-1R through interactions with the ECD (IC 50 value of 6 nM for the isolated ECD) <ref type="bibr" target="#b26">(27,</ref><ref type="bibr" target="#b31">32)</ref>. We recently solved the crystal structure of the GLP-1R ECD in complex with exendin-4(9 -39) (18). Exendin-4(9 -39) is ␣-helical in the ECD-bound conformation except for the C-terminal segment, the so-called Trp cage <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b33">34)</ref>. In solution, the helical propensity of exendin-4 is higher than that of GLP-1 <ref type="bibr" target="#b26">(27,</ref><ref type="bibr" target="#b32">33)</ref>. Biophysical studies showed a positive correlation between ␣-helical propensity in solution and affinity for the GLP-1R ECD <ref type="bibr" target="#b26">(27)</ref>. Moreover, charged residues of exendin-4 interact with the ECD in a manner not possible for GLP-1 <ref type="bibr" target="#b17">(18)</ref>. Hence, the high affinity of exendin-4 for the ECD may be a combination of high helical propensity in solution and unique receptor interactions.</p><p>Here, we report the crystal structure of the GLP-1R ECD in complex with its endogenous agonist GLP-1. We supplemented the crystal structure with site-directed mutagenesis to link the structural information of the isolated ECD with the binding properties of the full-length receptor.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EXPERIMENTAL PROCEDURES</head><p>Protein and Peptide Preparation-The GLP-1R ECD was prepared as described previously <ref type="bibr" target="#b26">(27)</ref>. Briefly, N-terminal His 6tagged ECD was expressed in Escherichia coli inclusion bodies, isolated as inclusion body protein, solubilized in guanidine-HCl and dithiothreitol, dialyzed against guanidine-HCl to remove the dithiothreitol, and refolded using L-Arg and a 1:5 molar ratio of reduced and oxidized glutathione. The refolded ECD was purified by hydrophobic interaction chromatography and size exclusion chromatography in 10 mM Tris-HCl, pH 7.5, 0.1 M Na 2 SO 4 , 2% glycerol. The His 6 tag was removed by thrombin cleavage. The purified GLP-1R ECD consisted of four amino acids, Gly-Ser-His-Met, of the linker attached to the N-terminus of ECD (Arg 24 -Tyr 145 ), M r ϭ 14,723 g/mol after removal of the His 6 tag. Native GLP-1(7-37)-OH was synthesized as described previously <ref type="bibr" target="#b11">(12)</ref>.</p><p>Purification and Crystallization of the GLP-1-bound Extracellular Domain-The purified GLP-1R ECD was concentrated to 1.2 mg/ml, mixed with 3-fold molar excess of GLP-1(7-37) (dissolved in 50 mM Tris-HCl, pH 7.5), and incubated overnight at 4°C. The GLP-1-bound ECD was purified by size exclusion chromatography on a Superdex 75 column in 10 mM Tris-HCl, pH 7.5, at a flow rate of 0.3 ml/min and characterized by SDS-PAGE (supplemental <ref type="figure" target="#fig_0">Fig. S1</ref>). The complex was concentrated to 4 mg/ml and crystallized by hanging drop vapor diffusion. The crystallization conditions were initially identified using the Crystal Screen from Hampton Research and subsequently optimized to 0.1 M N(2-acetamido)iminodiacetic acid, pH 6.9, 14 volume % (Ϯ)-2-methyl-2,4-pentanediol and 9 mM n-decyl-␤-D-thiomaltoside. Single crystals were flashed cooled in liquid N 2 using 30% glycerol in the cryo solution.</p><p>Data Collection and Structure Determination-Diffraction data were collected from a single crystal using beamline 1911-3 at MAX-lab (Lund, Sweden). The data were integrated and scaled using XDS <ref type="bibr" target="#b34">(35)</ref>. The crystals belonged to space group P2 1 22 1 with the unit cell dimensions a ϭ 35.7 Å, b ϭ 42.7 Å, and c ϭ 95.1 Å. The phases and electron density map were obtained by molecular replacement using Phaser running in the CCP4 program interface with one complex in the asymmetric unit. Refinement was done using COOT <ref type="bibr" target="#b35">(36)</ref> and REFMAC5 <ref type="bibr" target="#b36">(37)</ref>. Well defined electron density was obtained for GLP-1 residues Thr 11 *-Val 33 * and for ECD residues Val 30 -Glu 128 . Poor density was observed for GLP-1 residues Gly 10 *, Lys 34 *, and Gly 35 * and ECD residues Thr 29 and Asn 115 . No electron density was observed for His 7 *-Glu 9 * and Arg 36 *-Gly 37 * of GLP-1. Our final structure contains GLP-1 residues Gly 10 *-Gly 35 * and ECD residues Thr 29 -Glu 128 , but it should be noted that the conformation of Lys 34 * of GLP-1 is very uncertain, and because of the poor density we have chosen to show Asn 115 as Gly. The final GLP-1-bound ECD structure has 116 residues in preferred regions, 5 in allowed regions and only 1 outlier (Glu 68 in the ␤-turn between ␤ 1 and ␤ 2 shown in <ref type="figure" target="#fig_0">Fig. 1A</ref>) in the Ramachandran plot. The structure containing 73 water molecules and a detergent molecule (n-decyl-␤-D-thiomaltoside) has a working R-factor of 0.181% and a free R-factor of 0.226%. Data collection and refinement statistics are summarized in <ref type="table" target="#tab_0">Table 1</ref>. Coordinates and structure factors are deposited in the Protein Data Bank under accession code 3IOL. Molecular graphics were prepared in PyMOL <ref type="bibr" target="#b45">(46)</ref>.</p><p>Receptor Constructs-The cDNA encoding the human GLP-1R was originally obtained from Dr. B. Thorens <ref type="bibr" target="#b8">(9)</ref> and subcloned into the mammalian expression vector pcDNA3.1/ v5-His-TOPO (Invitrogen). The presence of the C-terminal His 6 tag was previously shown not to influence the functional response of the receptor <ref type="bibr" target="#b11">(12)</ref>. Site-directed mutagenesis of GLP-1R was done using QuikChange TM (Stratagene). Plasmid DNA was generated using the NucleoBond Xtra Maxi Plus kit (Macherey-Nagel), and the desired mutations were confirmed by dideoxynucleotide sequencing.</p><p>Cell Culture and Receptor Expression-Human embryonic kidney (HEK) 293 cells were maintained in Dulbecco's modified Eagle's medium (BioWhittaker) supplemented with 10 volume % fetal bovine serum and 1 volume % penicillin/streptomycin (100 units/ml) in T175 flasks. HEK293 cells were transiently transfected with 21 g of GLP-1R DNA using the FuGENE TM transfection reagent (Roche Applied Science), harvested 24 h after transfection, and used directly in functional experiments or plasma membrane preparations as described previously <ref type="bibr" target="#b11">(12)</ref>.</p><p>Functional Assay-Transiently transfected HEK293 cells expressing wild-type GLP-1R or mutant receptors were harvested and resuspended in assay buffer (Flashplate, PerkinElmer Life Sciences) to a cell density of 2.4 ϫ 10 6 cells/ ml. GLP-1(7-37)-acid and exendin-4 were diluted in phosphate-buffered saline with 0.02 volume % Tween 20. Cells in assay buffer (50 l) and GLP-1 or exendin-4 (50 l) were mixed in 96-well FlashPlates (PerkinElmer Life Sciences), gently agitated for 5 min, and incubated for 25 min at room temperature. The resulting intracellular level of cAMP was measured according to supplier's manual and analyzed by nonlinear regression/ sigmoidal dose-response fitting using Prism 5.0 (GraphPad Software, Inc.).</p><p>Receptor Binding Assay-Freshly thawed plasma membrane preparations from transiently transfected HEK293 cells expressing GLP-1R (20 g protein/well) were pulled through a 25-gauge needle three times and diluted in assay buffer (50 mM HEPES, 5 mM MgCl 2 , 5 mM EGTA, 0.005 volume % Tween 20, pH 7.4). GLP-1 and exendin-4 were diluted in assay buffer. The concentration range was 1 pM to 100 nM for GLP-1 and exendin-4. 125 I-GLP-1(7-36)-amide (2.2 Ci/mol) was dissolved in assay buffer and added at 50,000 cpm per well to a final concentration of 50 pM. Nonspecific binding was determined with 1 M GLP-1. Membrane preparation and radioligand were mixed in 96-well 0.65-m filter plates (Millipore) with either diluted GLP-1 or exendin-4 and incubated for 1 h at 37°C. Subsequently, bound and unbound radioligands were separated by vacuum filtration (Millipore vacuum manifold). The filters were washed twice in 100 l of cold assay buffer and left to dry. Data were analyzed by nonlinear regression, and the expression level (B max ) was calculated using Prism 5.0 (GraphPad Software, Inc.).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS AND DISCUSSION</head><p>Purification, Crystallization, and Structure Determination-The GLP-1R ECD was expressed in E. coli inclusion bodies, refolded, and purified as described previously <ref type="bibr" target="#b26">(27)</ref>. A complex of GLP-1 and the ECD was purified by size exclusion chromatography (supplemental <ref type="figure" target="#fig_0">Fig. S1</ref>). The purified complex was characterized by SDS-PAGE (supplemental <ref type="figure" target="#fig_0">Fig.  S1</ref>), concentrated, and crystallized by hanging drop vapor diffusion. Diffraction data were collected from a single crystal using the beamline 1911-3 at MAX-lab (Lund, Sweden), and the structure of GLP-1 in complex with the GLP-1R ECD was solved to 2.1 Å resolution by molecular replacement <ref type="figure" target="#fig_0">(Fig.  1A)</ref>. We removed exendin-4(9 -39) from the structure of the exendin-4(9 -39)-ECD complex (Protein Data Bank code 3C59) and used the apo-form of GLP-1R ECD as the search model for the molecular replacement. GLP-1 was then built into the model; its position was unambiguous due to good electron density for most of the ligand. Data collection and refinement statistics are summarized in <ref type="table" target="#tab_0">Table 1</ref>. Throughout the text, GLP-1 and exendin-4 residues are designated with * and **, respectively. Exendin-4 is numbered 1-39 and GLP-1 is numbered 7-37, due to post-translational processing. The aligned sequences are illustrated in <ref type="figure" target="#fig_0">Fig. 1B</ref>. Structure of the GLP-1R Extracellular Domain-The crystal structure of the ECD in the GLP-1-bound form shown here is very similar to the exendin-4(9 -39)-bound form shown previously (root mean square deviation of 0.79 Å for C ␣ atoms of the ECD) <ref type="bibr" target="#b17">(18)</ref>. The ligand-binding sites are identical, which is not surprising given the competitive binding of GLP-1 and exendin-4 for the full-length GLP-1R as well as the isolated ECD <ref type="bibr" target="#b26">(27)</ref>. However, we have previously shown that divergent residues in the two ligands are responsible for their different physical properties in solution and their different affinity for the ECD <ref type="bibr" target="#b26">(27)</ref>. As described below, these divergent residues give rise to structural differences in the two ligand-bound forms of the ECD at the level of specific side chain conformations.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Structure of GLP-1 and Its Interactions with the Extracellular Domain of GLP-1R-</head><p>GLP-1 is a continuous ␣-helix from Thr 13 * to Val 33 *, with a kink around Gly 22 *. The residues between Ala 24 * and Val 33 * interact with the ECD <ref type="figure" target="#fig_0">(Fig. 1, A and  B)</ref>. The amphiphilic nature of this ␣-helical segment enables hydrophilic and hydrophobic interactions through opposite faces of the ␣-helix. The hydrophilic face is comprised by residues Gln 23 *, Lys 26 *, Glu 27 *, and Lys 34 *. Lys 26 * is the only one of these that may interact directly with the ECD <ref type="figure" target="#fig_1">(Fig. 2A)</ref>. The side chain of Lys 26 * may form a hydrogen bond with the side chain of Glu 128 (ϳ3.0 Å), but the B-factor is rather high for both residues (ϳ25 compared with 10 for well defined residues), suggesting that this is not a strong interaction. In particular, the electron density of the Lys 26 * side chain is rather weak. In exendin-4(9 -39), the amphiphilic character is more pronounced, and the ␣-helical conformation is further stabilized by intramolecular interactions between Glu 16 **, Glu 17 **, Arg 20 **, Glu 24 **, and Lys 27 ** on the hydrophilic face <ref type="bibr" target="#b17">(18)</ref>. In addition, Arg 20 ** and Lys 27 ** interact with Glu 128 and Glu 127 of the ECD, respectively <ref type="bibr" target="#b17">(18)</ref>. The corresponding intramolecular stabilization is not possible in GLP-1 due to a less favorable alignment of oppositely charged residues <ref type="figure" target="#fig_0">(Fig. 1B)</ref>, and Glu 127 of the ECD is not involved in binding of GLP-1 ( <ref type="figure" target="#fig_1">Fig. 2A)</ref>.</p><p>The hydrophobic face of GLP-1, which interacts with the ECD, is defined by Ala 24 *, Ala 25 *, Phe 28 *, Ile 29 *, Leu 32 *, and Val 33 * <ref type="figure" target="#fig_1">(Fig. 2B)</ref>. The importance of Phe 28 *, Ile 29 *, and Leu 32 * in GLP-1 binding has been demonstrated previously by Ala scanning of GLP-1 <ref type="bibr" target="#b37">(38)</ref>. Substitution of Phe 28 * with Ala had the most severe effect on GLP-1 affinity in the Ala scan (IC 50 value increased by 1300-fold), and indeed Phe 28 * is centrally positioned in the ligand-receptor interface emphasizing the importance of this hydrophobic ligand-receptor interaction. The I29*A and L32*A substitutions also reduced GLP-1 affinity significantly (IC 50 value increased by 93-and 17-fold, respectively) <ref type="bibr" target="#b37">(38)</ref>. Trp 31 * is also on the hydrophobic face of GLP-1 but is rather solvent-exposed and does not interact with the ECD <ref type="figure" target="#fig_1">(Fig. 2B</ref>). Trp 31 * is conserved in the glucagon peptide family (GLP-1, exendin-4, glucagon, GIP, and GLP-2, see <ref type="figure" target="#fig_0">Fig. 1B</ref>), which implies a unique role of this residue. However, substitution of Trp 31 * with Ala only reduced the binding affinity of GLP-1 slightly at the full-length GLP-1R <ref type="bibr" target="#b37">(38)</ref>, so the role of Trp 31 * in receptor binding is unclear.</p><p>Val 33 * is the final residue in the ␣-helix of GLP-1, and it is the final residue in the C terminus of GLP-1 that interacts with the ECD <ref type="figure" target="#fig_1">(Fig. 2,  A and C)</ref>. The side chain of Val 33 * makes hydrophobic contacts with Tyr 69 and Leu 123 , and the backbone carbonyl of Val 33 * interacts through a hydrogen bond with one of the terminal nitrogens of Arg 121 <ref type="figure" target="#fig_1">(Fig. 2, A  and C)</ref>. The other terminal nitrogen of Arg 121 interacts with a water mol-  ecule, which is also coordinated by the backbone carbonyl groups of Asp 67 and Leu 32 * <ref type="figure" target="#fig_1">(Fig. 2C)</ref>. A water molecule is coordinated by the same residues in the exendin-4(9 -39)-bound ECD, and Arg 121 interacts with the backbone carbonyl of Lys 27 ** of exendin-4(9 -39) in a manner similar to the interaction with Val 33 * of GLP-1. Even though exendin-4 has a C-terminal nine-residue extension, the so-called Trp cage, the extent of the ␣-helix is similar for GLP-1 and exendin-4, and this particular length of the ␣-helix fits nicely into the ECD binding pocket.</p><p>Judging from the two ligand-bound ECD structures, the hydrophobic ligand-receptor interface is highly conserved, and the C-terminal ␣-helical structure of the ligands ends at the same position with a similar arrangement of receptor interactions mediated by the backbone of the ligand. Hence, the differential affinity for the ECD may best be explained by the lower ␣-helical propensity of GLP-1 in solution and by weaker receptor interactions compared with exendin-4, as suggested previously <ref type="bibr" target="#b26">(27)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Unique Structural Features of the GLP-1-bound Extracellular Domain-</head><p>The divergent residues in GLP-1 and exendin-4 are not only responsible for the different physical properties of the ligands in solution and their differential affinity for the GLP-1R ECD, they also influence the conformation of certain residues in the ECD structures. The crystal structure presented here suggests that one diverging residue in the two ligands (Val 33 * of GLP-1 and Lys 27 ** of exendin-4(9 -39)) causes a shift in the conformations of four residues in (or close to) the binding pocket of the ECD, namely Glu 127 , Leu 123 , Arg 121 , and Pro 119 <ref type="figure" target="#fig_2">(Fig. 3A)</ref>. In exendin-4(9 -39), Lys 27 ** interacts with Glu 127 , and the positioning of the Lys 27 ** side chain appears to be guided by a hydrophobic interaction with Leu 123 . In GLP-1, Val 33 * is unable to interact with Glu 127 causing Glu 127 to change rotamer conformation and point its side chain away from GLP-1. The side chain of Leu 123 is flipped toward Arg 121 , which again is flipped toward Pro 119 , thereby closing an otherwise water-accessible cavity observed in the exendin-4(9 -39)-bound structure <ref type="figure" target="#fig_2">(Fig. 3A)</ref>. The closing of this cavity is assisted by a side chain flip of Pro 119 toward Arg 121 . The apparent GLP-1-specific conformations affect the conserved core of the ECD by rotating the guanidine group of Arg 102 and by decreasing the distance between Asp 67 and Arg 102 compared with the exendin-4(9 -39)-bound structure without affecting the relative position and conformation of Trp 72 and Trp 110 <ref type="figure" target="#fig_2">(Fig.  3B</ref>). This enables a direct interaction through a hydrogen bond between Asp 67 and Arg 102 unlike what we observed in the exendin-4(9 -39)-bound structure, where a water molecule mediated the interaction between Asp 67 and Arg 102 <ref type="figure" target="#fig_2">(Fig. 3B)</ref>. The functional consequences of the ligand-specific conformational differences are not known.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Site-directed Mutagenesis of the GLP-1R-</head><p>To link the structural information of the isolated ECD with the binding and functional properties of the full-length receptor, we targeted the ligand-binding site of the ECD by site-directed mutagenesis. The mutants were characterized by their ability to bind GLP-1 and exendin-4, using the agonist 125 I-GLP-1 tracer, and by their ability to stimulate cAMP production in response to GLP-1 and exendin-4 ( <ref type="table" target="#tab_1">Table 2</ref>). The main objective was to search for mutations with differential effect on GLP-1 and exendin-4. We initially focused on Glu 127 , which showed an obvious conformational difference in the two ligand-bound structures <ref type="figure" target="#fig_2">(Fig. 3A)</ref>, Glu 127 interacts directly with exendin-4(9 -39) but not with GLP-1 <ref type="bibr" target="#b17">(18)</ref>. The ECD structures suggest that the hydrogen-bonding potential of Glu 127 is important for exendin-4 binding but not for binding of GLP-1, and this is supported by the site-directed mutagenesis data ( <ref type="table" target="#tab_1">Table 2)</ref>. Mutation of Glu 127 to Ala reduced the affinity for exendin-4 but not for GLP-1 (6.8versus 1.7-fold, respectively). Glu 128 interacts with a positively charged residue in both GLP-1 and exendin-4, which may explain why the E128A substitution did not have a differential effect on the binding affinity of GLP-1 and exendin-4. The differential effect of the E127A mutation on GLP-1 and exendin-4 binding is rather small compared with the differential affinity of the isolated ECD shown previously <ref type="bibr" target="#b26">(27)</ref>. Clearly, the superior helical propensity of exendin-4 contributes strongly to its high affinity for the ECD.</p><p>Several interactions are conserved in the two ECD structures, and mutagenesis of the implicated receptor residues was not expected to have differential effects on ligand binding <ref type="table" target="#tab_1">(Table 2)</ref>. Surprisingly, the L32A mutation reduced both the affinity and potency of exendin-4 relative to GLP-1 (7.1-and 9.5-fold, respectively, see <ref type="table" target="#tab_1">Table 2</ref> and <ref type="figure" target="#fig_3">Fig. 4)</ref>, demonstrating a ligandspecific effect of the L32A mutation. Neither the potency nor the affinity of GLP-1 was affected by the L32A mutation <ref type="figure" target="#fig_3">(Fig. 4)</ref>, and the expression level of the receptor was similar to wild-type GLP-1R, which confirmed the structural integrity of this receptor mutant. Leu 32 is the first residue in the ␣-helix of the GLP-1R ECD, and it defines the border of the hydrophobic binding cavity by interacting with Ala 24 *, Ala 25 *, and Phe 28 * <ref type="figure" target="#fig_1">(Fig. 2B)</ref>. The results suggest that Leu 32 is important for the binding of exendin-4 but not for the binding of GLP-1 to GLP-1R. It is difficult to give a structural explanation of the ligand-specific effect of the L32A mutation by comparing the two ligand-bound forms of the ECD, because the structural differences in this region are quite subtle. Nevertheless, the ligand-specific effect of the L32A mutation supports the existence of differences in the binding modes of GLP-1 and exendin-4 to the full-length GLP-1R. Clearly, the two-domain binding mechanism of the full-length GLP-1R is more complex than binding of the isolated ECD.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conformation of GLP-1, Receptor-bound and in Solution-</head><p>GLP-1 is highly flexible in aqueous buffers, whereas in trifluoroethanol a singlestranded ␣-helix forms (Thr 13 * to Lys 34 *) with a less defined ␣-helical region around Gly 22 *, as demonstrated by NMR spectroscopy <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b38">39)</ref>. Structure-activity studies of GLP-1 showed that side chain to side chain cyclization by lactam bridge formation of residues 16 -20 and 18 -22 were well tolerated. Cyclization of residues 11-15 improved potency for GLP-1R compared with the linear coun-  terpart <ref type="bibr" target="#b39">(40,</ref><ref type="bibr" target="#b40">41)</ref>. These data support the existence of an ␣-helical conformation in the N-terminal part of GLP-1 when bound to the full-length GLP-1R. It is interesting that in the ECD-bound structure, the Thr 13 *-Glu 21 * segment of GLP-1 adopts an ␣-helical conformation even though this segment does not interact with the ECD. The C-terminal segment of GLP-1 (Ala 24 *-Val 33 *) is stabilized in a specific ␣-helical conformation through binding to the ECD. This may subsequently stabilize an ␣-helical conformation in the N-terminal part of the ligand (Thr 13 *-Glu 21 *). This hypothesis is supported by the solution structure of GLP-1 in different concentrations of trifluoroethanol <ref type="bibr" target="#b38">(39)</ref>. GLP-1 is a random coil in pure water, but adding trifluoroethanol enables the C-terminal segment of GLP-1 to adopt an ␣-helix conformation. The C-terminal ␣-helix is gradually extended toward the N-terminus of the peptide with increasing concentrations of trifluoroethanol <ref type="bibr" target="#b38">(39)</ref>, and it seems possible that a similar mechanism is initiated upon binding of GLP-1 to the ECD. It was recently proposed that ␣-helix for-mation of the ligand upon binding to the ECD is an important step in the activation of class B GPCRs <ref type="bibr" target="#b22">(23)</ref>.</p><p>As shown in <ref type="figure" target="#fig_4">Fig. 5A</ref>, the ␣-helix of GLP-1 has a central distortion of the backbone around Gly 22 *, which is not observed in the exendin-4(9 -39)-bound structure. The distortion is also observed in the NMR structures of GLP-1 in solution <ref type="bibr" target="#b38">(39)</ref>. However, we cannot exclude that the kink observed in the crystal structure is a result of crystal packing between the N-terminal part of GLP-1 (Gly 10 *-Glu 21 *) and symmetry-related ECDs rather than a functionally important characteristic of GLP-1 <ref type="figure" target="#fig_4">(Fig. 5, B-D)</ref>. Substitution of Gly 22 * with Ala was previously shown not to affect the functionality or the binding affinity of GLP-1, which suggests that flexibility around Gly 22 * is not required for binding to or activation of GLP-1R <ref type="bibr" target="#b37">(38)</ref>. Interestingly, Leu 32 of the ECD is positioned right next to the kink of GLP-1 <ref type="figure" target="#fig_4">(Fig.  5A)</ref>. Thus, we have demonstrated a ligand-specific effect of the L32A mutation and have shown that ECD-bound GLP-1 has a kink right next to Leu 32 , whereas ECD-bound exendin-4(9 -39) is straight. This may be a coincidence, but it is tempting to speculate that there is a connection between the structural difference of the ligands (kinked or straight helix) and the differential effect of the L32A mutant on binding of the ligands.</p><p>A three-dimensional model of GLP-1R was recently published <ref type="bibr" target="#b20">(21)</ref>. From the NMR structure of GLP-1 in trifluoroethanol (Protein Data Bank code 1D0R (39)), it was suggested that GLP-1 might assume one of two forms when bound to GLP-1R, a slightly kinked ␣-helix or an L-shaped ␣-helix, and the authors concluded that the L-shaped ␣-helix conformation of GLP-1 seemed more reasonable <ref type="bibr" target="#b20">(21)</ref>. The crystal structure presented here is more compatible with the kinked conformation of GLP-1.</p><p>The structure of His 7 *-Gly 10 * was not determined in this study probably due to the inherent flexibility in this part of GLP-1 and other peptide ligands for class B receptors <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b42">43)</ref>. The only structural evidence showing a unique conformation comes from a structural study of PACAP(1-21) comparing micelle-and receptor-bound states. Residues 1-7 of PACAP(1-21) adopt a specific ␤-coil structure upon receptor binding followed by an ␣-helical structure of residues 8 -21 <ref type="bibr" target="#b43">(44)</ref>. The relevance of the receptor-bound PACAP(1-21) structure for GLP-1 in particular is supported by a previous study of chimeric PACAP/GLP-1 peptides <ref type="bibr" target="#b44">(45)</ref>. Substituting five residues from the N-terminus of GLP-1 with those of PACAP (three nonconserved, <ref type="figure" target="#fig_0">Fig. 1B</ref>) had no effect on either the affinity or potency for GLP-1R. Thus, on the basis of both sequence homology and structure-activity, GLP-1 would be expected to adopt a similar conformation upon binding to the GLP-1R TM domain.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion-</head><p>The crystal structure presented here shows the molecular details of GLP-1 binding to the GLP-1R ECD, an essential step in the two-domain binding mechanism of GLP-1R and class B GPCRs in general. Collectively, results from structural characterization of GLP-1 in solution, structure-activity analyses of GLP-1 analogues, and the crystal structure of GLP-1 bound to the GLP-1R ECD presented here suggest that GLP-1 is a continuous ␣-helix from Thr 13 * to Val 33 * when bound to the full-length GLP-1R. This is important information for the design of peptide therapeutics targeting GLP-1R. GLP-1 and exendin-4 share the same binding site of the GLP-1R ECD, but the ligand-specific effects on the ECD structure and the ligand-specific effects of receptor mutagenesis support the existence of differences in the binding modes of GLP-1 and exendin-4 to the full-length GLP-1R. The nature of these differences as well as the active conformation of peptide agonists (kinked or not) and a better understanding of the twodomain binding mechanism await structural characterization of the full-length GLP-1R.</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc>Structure of the GLP-1-bound ECD of the GLP-1R. A, stereoview of GLP-1 (blue) bound to the ECD of the GLP-1R (␣-helix in black, ␤-strands in red, and loops in gray). Disulfide bridges are shown as orange sticks. Residues Cys 62 -Asp 67 (␤ 1 ) and Ala 70 -Gly 75 (␤ 2 ) constitute the first region of antiparallel ␤-sheets, and the second region is comprised of residues Gly 78 -Ser 84 (␤ 3 ) and His 99 -Thr 105 (␤ 4 ), which is shown in red. Our final structure contains GLP-1 residues Gly 10 *-Gly 35 *. The residues that interact with GLP-1R ECD lie within Ala 24 * and Val 33 *, which are shown as sticks. B, sequence alignment of GLP-1, exendin-4, GIP, GLP-2, glucagon, and PACAP(1-27). Fully conserved residues are highlighted in yellow, and partially conserved residues are highlighted in green. The residues of GLP-1 and exendin-4 that interact with GLP-1R ECD are colored blue. The underlined residues symbolize residues of GLP-1 in ␣-helical conformation when bound to the ECD. Residue number 1 of exendin-4 corresponds to residue number 7 of GLP-1.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 2 .</head><label>2</label><figDesc>Interactions between GLP-1 and GLP-1R ECD. A, ribbon diagram of GLP-1 and its hydrophilic interactions with GLP-1R ECD. GLP-1 is colored in cyan, and residues Gln 23 *, Lys 26 *, Glu 27 *, Trp 31 *, and Val 33 * are illustrated as sticks. Receptor residues Arg 121 , Leu 123 , Glu 127 , and Glu 128 are shown as sticks. The surface of the hydrophilic binding cavity of ECD is illustrated in gray. B, ribbon diagram of GLP-1 and its hydrophobic interactions with GLP-1R ECD. GLP-1 residues Ala 24 *, Glu 27 *, Phe 28 *, Trp 31 *, and Leu 32 * are illustrated as sticks, and so are ECD residues Leu 32 , Trp 39 , Asp 67 , and Arg 121 . The surface of the hydrophobic binding cavity of ECD is illustrated in gray. C, ribbon diagram illustrating a common motif found in the GLP-1R ECD and in the GIP receptor ECD. The side chain of Arg 121 interacts with the backbone carbonyls of Asp 67 and Leu 32 * through a water molecule. GLP-1 residues Leu 32 * and Val 33 * are illustrated as sticks, and so are ECD residues Asp 67 and Arg 121 .</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 3 .</head><label>3</label><figDesc>Differences between the GLP-1-and exendin-4(9 -39)-bound structure of ECD. Ribbon diagrams showing significant differences in side chain conformations between the GLP-1-bound structure and the exendin-4(9 -39)-bound structure of GLP-1R ECD. Receptor and ligand residues are highlighted in blue for the GLP-1-bound structure and in orange for the exendin-4(9 -39)-bound structure. Water molecules in orange are present only in the exendin-4(9 -39)-bound structure. A, one diverging residue, Val 33 * of GLP-1 and Lys 27 ** of exendin-4(9 -39), causes a shift in the conformations of four residues, namely Glu 127 , Leu 123 , Arg 121 , and Pro 119 . B, GLP-1-specific conformations affect the conserved core of the ECD by rotating the guanidine group of Arg 102 and by decreasing the distance between Asp 67 and Arg 102 compared with the exendin-4(9 -39)-bound structure without affecting the relative position of Trp 72 and Trp 110 .</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIGURE 4 .</head><label>4</label><figDesc>Functional and binding properties of the L32A GLP-1R mutant. Upper panel, stimulation of cAMP production by transiently transfected HEK293 cells expressing the L32A mutant by GLP-1 (squares, A) and exendin-4 (circles, B). Dashed dose-response curves represent cAMP production by GLP-1 and exendin-4 at the wild-type GLP-1R, respectively. Lower panel, competition binding assay on plasma membranes from transiently transfected HEK293 cells expressing the L32A mutant. GLP-1 binding curves are presented with squares (C) and exendin-4 curves with circles (D). Dashed binding curves represent 125 I-GLP-1 displacement by GLP-1 and exendin-4 at the wild-type GLP-1R. Data are normalized according to 125 I-GLP-1 binding and correspond to three independent experiments performed in duplicate.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIGURE 5 .</head><label>5</label><figDesc>Crystal packing. A, superposition of ECD-bound GLP-1 (blue) and exendin-4(9 -39) (cyan). GLP-1 residue Gly 22 * denotes a kink in the ␣-helix, which is situated in close proximity to Leu 32 of the ECD. B, crystal packing involving symmetry-related complex molecules. C, ribbon diagram of GLP-1 (blue) and its interactions with the ligand of a symmetry-related molecule. Residues Tyr 19 *, Gln 23 *, and Glu 27 * are shown as sticks, and the surface of the GLP-1R ECD is shown in gray. The packing of complex molecules allows Tyr 19 * to interact with Gln 23 * (3 Å) and Glu 27 * (2.5 Å) in a symmetry-related ligand molecule. D, interactions between GLP-1 and residues of symmetry-related ECD molecules. GLP-1 residues Thr 11 * , Thr 13 *, Ser 14 *, and Glu 21 * are shown as sticks. The backbone carbonyl of Thr 11 * could form a weak hydrogen bond (3.2 Å) to the backbone amide of Gln 112 , the backbone amide of Thr 13 * could form a hydrogen bond (2.9 Å) to the backbone carbonyl of Gln 112 , and the backbone amide of Ser 14 * may form a hydrogen bond (3 Å) to the side chain of Asp 114 . The side chain of Glu 21 * forms a hydrogen bond to the backbone amide of Phe 80 (2.6 Å).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1 Data collection and refinement statistics</head><label>1</label><figDesc></figDesc><table><row><cell cols="2">The data set was collected from a single crystal. Values in parentheses are for the</cell></row><row><cell>highest resolution shell (2.2-2.1 Å).</cell><cell></cell></row><row><cell>Space group</cell><cell>P2 1 22 1</cell></row><row><cell>Unit cell dimensions (Å)</cell><cell></cell></row><row><cell>A</cell><cell>35.7</cell></row><row><cell>B</cell><cell>42.7</cell></row><row><cell>C</cell><cell>95.1</cell></row><row><cell>Data collection</cell><cell></cell></row><row><cell>Wavelength</cell><cell>1.0 Å</cell></row><row><cell>Resolution range</cell><cell>95.1-2.1 Å (2.2-2.1 Å)</cell></row><row><cell>Total reflections</cell><cell>73,811</cell></row><row><cell>Unique reflections</cell><cell>10,348</cell></row><row><cell>Completeness</cell><cell>97.9%</cell></row><row><cell>I/(I)</cell><cell>14.0 (5.3)</cell></row><row><cell>R sym</cell><cell>11.1 (44.9)</cell></row><row><cell>Refinement statistics</cell><cell></cell></row><row><cell>No. of non-hydrogen atoms</cell><cell>1109</cell></row><row><cell>Resolution</cell><cell>95.1-2.1 Å (2.155-2.100 Å)</cell></row><row><cell>Total reflections</cell><cell>8786</cell></row><row><cell>Reflections in test set</cell><cell>429</cell></row><row><cell>R work</cell><cell>0.181 (0.187)</cell></row><row><cell>R free</cell><cell>0.226 (0.255)</cell></row><row><cell>Average B-factors</cell><cell>13.6</cell></row><row><cell>Root mean square deviation</cell><cell></cell></row><row><cell>Bond lengths</cell><cell>0.02 Å</cell></row><row><cell>Bond angles</cell><cell>1.7°C</cell></row></table><note>rystal Structure of Receptor-bound GLP-1</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2 Functional and binding experiments with GLP-1R mutants</head><label>2</label><figDesc>50  and IC 50 values are given in pM and nM, respectively, and expression levels are given in fmol/mg total protein. Data represent the mean Ϯ S.E. of three or more independent experiments performed in duplicate. The EC 50 or IC 50 values of GLP-1 and exendin-4 are compared with the wild-type GLP-1R using the unpaired t test. Numbers in parentheses equal the relative difference between EC 50 or IC 50 values of GLP-1 and exendin-4 at each mutant compared with the wild-type receptor. ND means not detectable, possibly due to no expression or no binding. * indicates p Ͻ 0.05; **, p Ͻ 0.01; and no asterisk means no significant difference.</figDesc><table><row><cell>EC Mutant</cell><cell>GLP-1</cell><cell>EC 50</cell><cell>Exendin-4</cell><cell>GLP-1</cell><cell>IC 50</cell><cell>Exendin-4</cell><cell>Expression level</cell></row><row><cell></cell><cell></cell><cell>pM</cell><cell></cell><cell></cell><cell>nM</cell><cell></cell><cell>fmol/mg</cell></row><row><cell>Wild type</cell><cell>11 Ϯ 3.2</cell><cell></cell><cell>5.5 Ϯ 1.7</cell><cell>1.0 Ϯ 0.20</cell><cell></cell><cell>0.76 Ϯ 0.19</cell><cell>5.5 Ϯ 0.16</cell></row><row><cell>L32A</cell><cell>12 Ϯ 2.7 (1.1)</cell><cell></cell><cell>52 Ϯ 24 (9.5)</cell><cell>1.1 Ϯ 0.17 (1.1)</cell><cell></cell><cell>5.4 Ϯ 1.5* (7.1)</cell><cell>6.0 Ϯ 0.40</cell></row><row><cell>T35A</cell><cell>30 Ϯ 7.4 (2.7)</cell><cell></cell><cell>23 Ϯ 12 (4.2)</cell><cell>3.1 Ϯ 0.80 (3.1)</cell><cell></cell><cell>0.44 Ϯ 0.1** (0.6)</cell><cell>0.38 Ϯ 0.01</cell></row><row><cell>V36A</cell><cell>57 Ϯ 32 (5.2)</cell><cell></cell><cell>36 Ϯ 20 (6.5)</cell><cell>2.8 Ϯ 0.86 (2.8)</cell><cell></cell><cell>0.98 Ϯ 0.34 (1.3)</cell><cell>5.7 Ϯ 0.28</cell></row><row><cell>E68A</cell><cell>15 Ϯ 2.4 (1.4)</cell><cell></cell><cell>9.5 Ϯ 4.2 (1.7)</cell><cell>1.9 Ϯ 0.90 (1.9)</cell><cell></cell><cell>0.48 Ϯ 0.07 (0.6)</cell><cell>5.7 Ϯ 0.07</cell></row><row><cell>Y69A</cell><cell>ND</cell><cell></cell><cell>ND</cell><cell>ND</cell><cell></cell><cell>ND</cell><cell>ND</cell></row><row><cell>Y88A</cell><cell>ND</cell><cell></cell><cell>ND</cell><cell>ND</cell><cell></cell><cell>ND</cell><cell>ND</cell></row><row><cell>L89A</cell><cell>ND</cell><cell></cell><cell>ND</cell><cell>ND</cell><cell></cell><cell>ND</cell><cell>ND</cell></row><row><cell>P90A</cell><cell>55 Ϯ 12* (5.0)</cell><cell></cell><cell>30 Ϯ 7.3* (5.5)</cell><cell>2.8 Ϯ 1.6 (2.8)</cell><cell></cell><cell>1.6 Ϯ 0.28 (2.1)</cell><cell>5.6 Ϯ 0.22</cell></row><row><cell>R121A</cell><cell>51 Ϯ 13* (4.6)</cell><cell></cell><cell>44 Ϯ 10* (8.0)</cell><cell>2.3 Ϯ 1.1 (2.3)</cell><cell></cell><cell>1.2 Ϯ 0.02 (1.6)</cell><cell>5.7 Ϯ 0.37</cell></row><row><cell>L123A</cell><cell>17 Ϯ 4.6 (1.5)</cell><cell></cell><cell>9.5 Ϯ 1.9 (1.7)</cell><cell>1.1 Ϯ 0.38 (1.1)</cell><cell></cell><cell>0.33 Ϯ 0.04 (0.4)</cell><cell>2.6 Ϯ 0.09</cell></row><row><cell>E127A</cell><cell>13 Ϯ 4.2 (1.2)</cell><cell></cell><cell>11 Ϯ 0.45* (2.0)</cell><cell>1.7 Ϯ 0.76 (1.7)</cell><cell></cell><cell>5.2 Ϯ 2.0 (6.8)</cell><cell>5.6 Ϯ 0.46</cell></row><row><cell>E127Q</cell><cell>12 Ϯ 3.3 (1.1)</cell><cell></cell><cell>6.8 Ϯ 1.4 (1.2)</cell><cell>1.1 Ϯ 0.27 (1.1)</cell><cell></cell><cell>0.82 Ϯ 0.15 (1.1)</cell><cell>6.11 Ϯ 0.21</cell></row><row><cell>E128A</cell><cell>28 Ϯ 6.2 (2.5)</cell><cell></cell><cell>25 Ϯ 6.7* (4.5)</cell><cell>2.7 Ϯ 0.91 (2.7)</cell><cell></cell><cell>1.8 Ϯ 0.48 (2.4)</cell><cell>6.0 Ϯ 0.49</cell></row><row><cell>E128Q</cell><cell>10 Ϯ 3.0 (0.9)</cell><cell></cell><cell>8.0 Ϯ 3.3 (1.5)</cell><cell>0.66 Ϯ 0.11 (0.7)</cell><cell></cell><cell>0.45 Ϯ 0.1 (0.6)</cell><cell>5.2 Ϯ 0.12</cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">VOLUME 285 • NUMBER 1 • JANUARY 1, 2010</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">JANUARY 1, 2010 • VOLUME 285 • NUMBER 1 JOURNAL OF BIOLOGICAL CHEMISTRY 725</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">JANUARY 1, 2010 • VOLUME 285 • NUMBER 1 JOURNAL OF BIOLOGICAL CHEMISTRY 727</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">JANUARY 1, 2010 • VOLUME 285 • NUMBER 1 JOURNAL OF BIOLOGICAL CHEMISTRY 729</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgments-We thank Lone Bayer and Thomas S. Harkes for skillful laboratory assistance, the staff at the MAX-lab beamline I911-3 for technical help during data collection, and Henning</head><p>Thøgersen for discussions.</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Mojsov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Heinrich</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><forename type="middle">B</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Ravazzola</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Orci</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Habener</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">261</biblScope>
			<biblScope unit="page" from="11880" to="11889" />
			<date type="published" when="1986" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Glucagon-like peptide-1 but not glucagon-like peptide-2 stimulates insulin release from isolated rat pancreatic islets</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">E</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">G</forename><surname>Siegel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Creutzfeldt</surname></persName>
		</author>
		<idno type="DOI">10.1007/bf00291980</idno>
		<idno type="PMID">3905480</idno>
		<idno type="ark">ark:/67375/1BB-BBWCN09R-0</idno>
		<idno type="istexId">E25971BBDECD215D70E39AA407DCA6701F00D2F8</idno>
		<ptr type="open-access" target="https://link.springer.com/content/pdf/10.1007%2FBF00291980.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetologia</title>
		<title level="j" type="abbrev">Diabetologia</title>
		<idno type="ISSN">0012-186X</idno>
		<idno type="ISSNe">1432-0428</idno>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="704" to="707" />
			<date type="published" when="1985-09" />
			<publisher>Springer Nature America, Inc</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Flint</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Raben</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Astrup</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Holst</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci990</idno>
		<idno type="PMID">9449682</idno>
		<idno type="PMCID">PMC508592</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/990/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="515" to="520" />
			<date type="published" when="1998-02-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Effect of Truncated Glucagon-Like Peptide-1 [Proglucagon-(78–107) amide] on Endocrine Secretion from Pig Pancreas, Antrum, and Nonantral Stomach</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ørskov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Holst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><forename type="middle">V</forename><surname>Nielsen</surname></persName>
		</author>
		<idno type="DOI">10.1210/endo-123-4-2009</idno>
		<idno type="PMID">2901341</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<title level="j" type="abbrev">Endocrinology</title>
		<idno type="ISSN">0013-7227</idno>
		<idno type="ISSNe">1945-7170</idno>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="2009" to="2013" />
			<date type="published" when="1988-10" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Wettergren</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Schjoldager</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">E</forename><surname>Mortensen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Petersen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ørskov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">J</forename><surname>Holst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Digestion</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="384" to="385" />
			<date type="published" when="1993" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">A</forename><surname>Stoffers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">F</forename><surname>Habener</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Bonner-Weir</surname></persName>
		</author>
		<idno type="DOI">10.2337/diabetes.48.12.2270</idno>
		<idno type="PMID">10580413</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2270" to="2276" />
			<date type="published" when="1999-12-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">A role for glucagon-like peptide-1 in the central regulation of feeding</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">D</forename><surname>Turton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>O'shea</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">I</forename><surname>Gunn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>Beak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">M B</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Meeran</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">J</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">M</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">M</forename><surname>Heath</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">D</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P H</forename><surname>Wilding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">A</forename><surname>Ghatei</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Herbert</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Bloom</surname></persName>
		</author>
		<idno type="DOI">10.1038/379069a0</idno>
		<idno type="PMID">8538742</idno>
		<idno type="ark">ark:/67375/GT4-Z2GDQ1H7-Z</idno>
		<idno type="istexId">20B42F0FD9E02406B2128E3EF1393502F8266A7F</idno>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<title level="j" type="abbrev">Nature</title>
		<idno type="ISSN">0028-0836</idno>
		<idno type="ISSNe">1476-4687</idno>
		<imprint>
			<biblScope unit="volume">379</biblScope>
			<biblScope unit="issue">6560</biblScope>
			<biblScope unit="page" from="69" to="72" />
			<date type="published" when="1996-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Receptors for glucagon-like peptide-1(7–36) amide on rat insulinoma-derived cells</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">M</forename><surname>Conlon</surname></persName>
		</author>
		<idno type="DOI">10.1677/joe.0.1160357</idno>
		<idno type="PMID">2832504</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Endocrinology</title>
		<idno type="ISSN">0022-0795</idno>
		<idno type="ISSNe">1479-6805</idno>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="357" to="362" />
			<date type="published" when="1988-03" />
			<publisher>Bioscientifica</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Thorens</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.89.18.8641</idno>
		<idno type="PMID">1326760</idno>
		<idno type="PMCID">PMC49976</idno>
		<ptr type="open-access" target="https://www.pnas.org/content/pnas/89/18/8641.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="8641" to="8645" />
			<date type="published" when="1992-09-15" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Foord</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">I</forename><surname>Bonner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">R</forename><surname>Neubig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">M</forename><surname>Rosser</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Pin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">P</forename><surname>Davenport</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Spedding</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">J</forename><surname>Harmar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol. Rev</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="279" to="288" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">P</forename><surname>Graziano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Hey</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">D</forename><surname>Strader</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Receptors Channels</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="9" to="17" />
			<date type="published" when="1996" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Runge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">S</forename><surname>Wulff</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Madsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Bräuner-Osborne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">B</forename><surname>Knudsen</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bjp.0705120</idno>
		<idno type="PMID">12642379</idno>
		<idno type="PMCID">PMC1573731</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1573731?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<idno type="ISSN">0007-1188</idno>
		<idno type="ISSNe">1476-5381</idno>
		<imprint>
			<biblScope unit="volume">138</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="787" to="794" />
			<date type="published" when="2003-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Hoare</surname></persName>
		</author>
		<idno type="DOI">10.1016/s1359-6446(05)03370-2</idno>
		<idno type="PMID">15808821</idno>
	</analytic>
	<monogr>
		<title level="j">Drug Discovery Today</title>
		<title level="j" type="abbrev">Drug Discovery Today</title>
		<idno type="ISSN">1359-6446</idno>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="417" to="427" />
			<date type="published" when="2005-03-15" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">NMR structure and peptide hormone binding site of the first extracellular domain of a type B1 G protein-coupled receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">R R</forename><surname>Grace</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">H</forename><surname>Perrin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Digruccio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">L</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">E</forename><surname>Rivier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">W</forename><surname>Vale</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Riek</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0404702101</idno>
		<idno type="PMID">15326300</idno>
		<idno type="PMCID">PMC516482</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/101/35/12836.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">35</biblScope>
			<biblScope unit="page" from="12836" to="12841" />
			<date type="published" when="2004-08-23" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Molecular Recognition of Corticotropin-releasing Factor by Its G-protein-coupled Receptor CRFR1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Augen</forename><forename type="middle">A</forename><surname>Pioszak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naomi</forename><forename type="middle">R</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kelly</forename><surname>Suino-Powell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Eric</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m805749200</idno>
		<idno type="PMID">18801728</idno>
		<idno type="PMCID">PMC2583312</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/283/47/32900.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="issue">47</biblScope>
			<biblScope unit="page" from="32900" to="32912" />
			<date type="published" when="2008-09-17" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Solution structure and mutational analysis of pituitary adenylate cyclase-activating polypeptide binding to the extracellular domain of PAC1-RS</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">A</forename><surname>Davis-Taber</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">W</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">E</forename><surname>Scott</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">L</forename><surname>Richardson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Pereda-Lopez</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Uchic</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">R</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">R</forename><surname>Lake</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">A</forename><surname>Walter</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">J</forename><surname>Hajduk</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">T</forename><surname>Olejniczak</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0611397104</idno>
		<idno type="PMID">17470806</idno>
		<idno type="PMCID">PMC1876540</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/104/19/7875.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="7875" to="7880" />
			<date type="published" when="2007-04-30" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Parthier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Kleinschmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Rudolph</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Manhart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Schlenzig</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Fanghanel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J-U</forename><surname>Rahfeld</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H-U</forename><surname>Demuth</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">T</forename><surname>Stubbs</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0706404104</idno>
		<idno type="PMID">17715056</idno>
		<idno type="PMCID">PMC1955799</idno>
		<ptr type="open-access" target="https://www.pnas.org/content/pnas/104/35/13942.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">Proceedings of the National Academy of Sciences</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="issue">35</biblScope>
			<biblScope unit="page" from="13942" to="13947" />
			<date type="published" when="2007-08-21" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Crystal Structure of the Ligand-bound Glucagon-like Peptide-1 Receptor Extracellular Domain</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steffen</forename><surname>Runge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henning</forename><surname>Thøgersen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kjeld</forename><surname>Madsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jesper</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rainer</forename><surname>Rudolph</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m708740200</idno>
		<idno type="PMID">18287102</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/283/17/11340.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">283</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="11340" to="11347" />
			<date type="published" when="2008-02-20" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Molecular recognition of parathyroid hormone by its G protein-coupled receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Augen</forename><forename type="middle">A</forename><surname>Pioszak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Eric</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0801027105</idno>
		<idno type="PMID">18375760</idno>
		<idno type="PMCID">PMC2278174</idno>
		<ptr type="open-access" target="http://www.pnas.org/content/105/13/5034.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Proceedings of the National Academy of Sciences</title>
		<title level="j" type="abbrev">PNAS</title>
		<idno type="ISSN">0027-8424</idno>
		<idno type="ISSNe">1091-6490</idno>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="5034" to="5039" />
			<date type="published" when="2008-03-28" />
			<publisher>Proceedings of the National Academy of Sciences</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suleiman</forename><surname>Al-Sabah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><surname>Donnelly</surname></persName>
		</author>
		<idno type="DOI">10.1038/sj.bjp.0705453</idno>
		<idno type="PMID">12970080</idno>
		<idno type="PMCID">PMC1574045</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1574045?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">British Journal of Pharmacology</title>
		<idno type="ISSN">0007-1188</idno>
		<idno type="ISSNe">1476-5381</idno>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="339" to="346" />
			<date type="published" when="2003-09" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fu</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Renxiao</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00894-008-0372-2</idno>
		<idno type="PMID">18941807</idno>
		<idno type="ark">ark:/67375/VQC-M4WMHH9J-2</idno>
		<idno type="istexId">4D1D7CB77A00CC51F068FE620A7CC1D555E3BFF5</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Modeling</title>
		<title level="j" type="abbrev">J Mol Model</title>
		<idno type="ISSN">1610-2940</idno>
		<idno type="ISSNe">0948-5023</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="53" to="65" />
			<date type="published" when="2008-10-22" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Structural basis of natural ligand binding and activation of the Class II G-protein-coupled secretin receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">J</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">G</forename><surname>Harikumar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Gao</surname></persName>
		</author>
		<idno type="DOI">10.1042/bst0350709</idno>
		<idno type="PMID">17635130</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/5dc7/50adf6d4487700169a724fe3eab6ad374589.pdf" />
	</analytic>
	<monogr>
		<title level="j">Biochemical Society Transactions</title>
		<title level="j" type="abbrev">Biochm. Soc. Trans.</title>
		<idno type="ISSN">0300-5127</idno>
		<idno type="ISSNe">1470-8752</idno>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="709" to="712" />
			<date type="published" when="2007-08-01" />
			<publisher>Portland Press Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Passing the baton in class B GPCRs: peptide hormone activation via helix induction?</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christoph</forename><surname>Parthier</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steffen</forename><surname>Reedtz-Runge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rainer</forename><surname>Rudolph</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Milton</forename><forename type="middle">T</forename><surname>Stubbs</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.tibs.2009.02.004</idno>
		<idno type="PMID">19446460</idno>
	</analytic>
	<monogr>
		<title level="j">Trends in Biochemical Sciences</title>
		<title level="j" type="abbrev">Trends in Biochemical Sciences</title>
		<idno type="ISSN">0968-0004</idno>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="303" to="310" />
			<date type="published" when="2009-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">A</forename><surname>Kleinman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">P</forename><surname>Raufman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">267</biblScope>
			<biblScope unit="page" from="7402" to="7405" />
			<date type="published" when="1992" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Cloning and Functional Expression of the Human Islet GLP-1 Receptor: Demonstration That Exendin-4 Is an Agonist and Exendin-(9-39) an Antagonist of the Receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Thorens</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Porret</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><surname>Buhler</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S-P</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Morel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Widmann</surname></persName>
		</author>
		<idno type="DOI">10.2337/diab.42.11.1678</idno>
		<idno type="PMID">8405712</idno>
		<ptr type="open-access" target="http://diabetes.diabetesjournals.org/content/diabetes/42/11/1678.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<title level="j" type="abbrev">Diabetes</title>
		<idno type="ISSN">0012-1797</idno>
		<idno type="ISSNe">1939-327X</idno>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1678" to="1682" />
			<date type="published" when="1993-11-01" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The Isolated N-terminal Domain of the Glucagon-like Peptide-1 (GLP-1) Receptor Binds Exendin Peptides with Much Higher Affinity than GLP-1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rakel</forename><surname>López De Maturana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angela</forename><surname>Willshaw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antje</forename><surname>Kuntzsch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rainer</forename><surname>Rudolph</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><surname>Donnelly</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.m212147200</idno>
		<idno type="PMID">12524435</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/278/12/10195.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="10195" to="10200" />
			<date type="published" when="2003-01-10" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Differential Structural Properties of GLP-1 and Exendin-4 Determine Their Relative Affinity for the GLP-1 Receptor N-Terminal Extracellular Domain†</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Steffen</forename><surname>Runge</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Susann</forename><surname>Schimmer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jan</forename><surname>Oschmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christine</forename><forename type="middle">Bruun</forename><surname>Schiødt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sanne</forename><forename type="middle">Möller</forename><surname>Knudsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Claus</forename><forename type="middle">Bekker</forename><surname>Jeppesen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kjeld</forename><surname>Madsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jesper</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henning</forename><surname>Thøgersen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rainer</forename><surname>Rudolph</surname></persName>
		</author>
		<idno type="DOI">10.1021/bi062309m</idno>
		<idno type="PMID">17444618</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<title level="j" type="abbrev">Biochemistry</title>
		<idno type="ISSN">0006-2960</idno>
		<idno type="ISSNe">1520-4995</idno>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="5830" to="5840" />
			<date type="published" when="2007-05" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">The positive charge at Lys-288 of the glucagon-like peptide-1 (GLP-1) receptor is important for binding the N-terminus of peptide agonists</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Suleiman</forename><surname>Al-Sabah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><surname>Donnelly</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0014-5793(03)01043-3</idno>
		<idno type="PMID">14572647</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Letters</title>
		<idno type="ISSN">0014-5793</idno>
		<imprint>
			<biblScope unit="volume">553</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="342" to="346" />
			<date type="published" when="2003-09-26" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rakel</forename><surname>López De Maturana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><surname>Donnelly</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0014-5793(02)03492-0</idno>
		<idno type="PMID">12387900</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Letters</title>
		<idno type="ISSN">0014-5793</idno>
		<imprint>
			<biblScope unit="volume">530</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="244" to="248" />
			<date type="published" when="2002-10-03" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Met-204 And Tyr-205 Are Together Important For Binding Glp-1 Receptor Agonists But Not Their N-Terminally Truncated Analogues</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Rakel</forename><surname>De Maturana</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Janet</forename><surname>Treece-Birch</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fatima</forename><surname>Abidi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Findlay</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dan</forename><surname>Donnelly</surname></persName>
		</author>
		<idno type="DOI">10.2174/0929866043478491</idno>
		<idno type="PMID">14965274</idno>
	</analytic>
	<monogr>
		<title level="j">Protein &amp; Peptide Letters</title>
		<title level="j" type="abbrev">PPL</title>
		<idno type="ISSN">0929-8665</idno>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="15" to="22" />
			<date type="published" when="2004-02-01" />
			<publisher>Bentham Science Publishers Ltd.</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">High Potency Antagonists of the Pancreatic Glucagon-like Peptide-1 Receptor</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chahrzad</forename><surname>Montrose-Rafizadeh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Huan</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Buel</forename><forename type="middle">D</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alvie</forename><surname>Beday</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Louella</forename><forename type="middle">A</forename><surname>Pritchette</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Eng</surname></persName>
		</author>
		<idno type="DOI">10.1074/jbc.272.34.21201</idno>
		<idno type="PMID">9261127</idno>
		<ptr type="open-access" target="http://www.jbc.org/content/272/34/21201.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Biological Chemistry</title>
		<title level="j" type="abbrev">J. Biol. Chem.</title>
		<idno type="ISSN">0021-9258</idno>
		<idno type="ISSNe">1083-351X</idno>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="issue">34</biblScope>
			<biblScope unit="page" from="21201" to="21206" />
			<date type="published" when="1997-08-22" />
			<publisher>American Society for Biochemistry &amp; Molecular Biology (ASBMB)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Göke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">C</forename><surname>Fehmann</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Linn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Krause</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Göke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">268</biblScope>
			<biblScope unit="page" from="19650" to="19655" />
			<date type="published" when="1993" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Exendin-4 and Glucagon-like-peptide-1: NMR Structural Comparisons in the Solution and Micelle-Associated States†</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">W</forename><surname>Neidigh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Matthew</forename><surname>Fesinmeyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathryn</forename><forename type="middle">S</forename><surname>Prickett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Niels</forename><forename type="middle">H</forename><surname>Andersen</surname></persName>
		</author>
		<idno type="DOI">10.1021/bi010902s</idno>
		<idno type="PMID">11683627</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<title level="j" type="abbrev">Biochemistry</title>
		<idno type="ISSN">0006-2960</idno>
		<idno type="ISSNe">1520-4995</idno>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">44</biblScope>
			<biblScope unit="page" from="13188" to="13200" />
			<date type="published" when="2001-11" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Designing a 20-residue protein</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">W</forename><surname>Neidigh</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">Matthew</forename><surname>Fesinmeyer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Niels</forename><forename type="middle">H</forename><surname>Andersen</surname></persName>
		</author>
		<idno type="DOI">10.1038/nsb798</idno>
		<idno type="PMID">11979279</idno>
		<idno type="ark">ark:/67375/GT4-WZ67NFGT-8</idno>
		<idno type="istexId">459F567B78BC1808D0737AE5ABFCF74C8BC9B590</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Structural Biology</title>
		<title level="j" type="abbrev">Nat. Struct Biol.</title>
		<idno type="ISSN">1072-8368</idno>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="425" to="430" />
			<date type="published" when="2002-04-29" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Kabsch</surname></persName>
		</author>
		<idno type="DOI">10.1107/s0021889893005588</idno>
		<idno type="ark">ark:/67375/WNG-5S3BG76Q-6</idno>
		<idno type="istexId">E1F7826C22629D0C31E3A169E10151FA3246A3A1</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Applied Crystallography</title>
		<title level="j" type="abbrev">J Appl Cryst</title>
		<idno type="ISSN">0021-8898</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="795" to="800" />
			<date type="published" when="1993-12-01" />
			<publisher>International Union of Crystallography (IUCr)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Coot: model-building tools for molecular graphics</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paul</forename><surname>Emsley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kevin</forename><surname>Cowtan</surname></persName>
		</author>
		<idno type="DOI">10.1107/s0907444904019158</idno>
		<idno type="PMID">15572765</idno>
		<idno type="ark">ark:/67375/WNG-3V6SCP6C-B</idno>
		<idno type="istexId">0D563BA8908DF746E924B484F1E7F7E37E579F26</idno>
		<ptr type="open-access" target="http://journals.iucr.org/d/issues/2004/12/01/ba5070/ba5070.pdf" />
	</analytic>
	<monogr>
		<title level="j">Acta Crystallographica Section D Biological Crystallography</title>
		<title level="j" type="abbrev">Acta Crystallogr D Biol Cryst</title>
		<idno type="ISSN">0907-4449</idno>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2126" to="2132" />
			<date type="published" when="2004-11-26" />
			<publisher>International Union of Crystallography (IUCr)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Refinement of Macromolecular Structures by the Maximum-Likelihood Method</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">N</forename><surname>Murshudov</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">A</forename><surname>Vagin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><forename type="middle">J</forename><surname>Dodson</surname></persName>
		</author>
		<idno type="DOI">10.1107/s0907444996012255</idno>
		<idno type="PMID">15299926</idno>
		<idno type="ark">ark:/67375/WNG-SC19VWN7-Z</idno>
		<idno type="istexId">20772399813DCC1B6E0C34477BD31DA08119EDED</idno>
	</analytic>
	<monogr>
		<title level="j">Acta Crystallographica Section D Biological Crystallography</title>
		<title level="j" type="abbrev">Acta Cryst D</title>
		<idno type="ISSN">0907-4449</idno>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="240" to="255" />
			<date type="published" when="1997-05-01" />
			<publisher>International Union of Crystallography (IUCr)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Adelhorst</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><forename type="middle">B</forename><surname>Hedegaard</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">B</forename><surname>Knudsen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">O</forename><surname>Kirk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Biol. Chem</title>
		<imprint>
			<biblScope unit="volume">269</biblScope>
			<biblScope unit="page" from="6275" to="6278" />
			<date type="published" when="1994" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Structure and folding of glucagon-like peptide-1-(7-36)-amide in aqueous trifluoroethanol studied by NMR spectroscopy</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoqing</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Danielle</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Søren</forename><surname>Bjørn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jens</forename><forename type="middle">J</forename><surname>Led</surname></persName>
		</author>
		<idno type="DOI">10.1002/mrc.880</idno>
		<idno type="ark">ark:/67375/WNG-43TKFC63-2</idno>
		<idno type="istexId">44304A5851497357203A65ECD1F08B75EC45F479</idno>
	</analytic>
	<monogr>
		<title level="j">Magnetic Resonance in Chemistry</title>
		<title level="j" type="abbrev">Magn. Reson. Chem.</title>
		<idno type="ISSN">0749-1581</idno>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="477" to="483" />
			<date type="published" when="2001-06-28" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Design and Synthesis of Conformationally Constrained Glucagon-Like Peptide-1 Derivatives with Increased Plasma Stability and Prolonged in Vivo Activity</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Les</forename><forename type="middle">P</forename><surname>Miranda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Katherine</forename><forename type="middle">A</forename><surname>Winters</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Colin</forename><forename type="middle">V</forename><surname>Gegg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ankita</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><surname>Aral</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jason</forename><surname>Long</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jingwen</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stephanie</forename><surname>Diamond</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><surname>Guido</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shanaka</forename><surname>Stanislaus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hongyan</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mark</forename><forename type="middle">J</forename><surname>Rose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Leszek</forename><surname>Poppe</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Murielle</forename><forename type="middle">M</forename><surname>Véniant</surname></persName>
		</author>
		<idno type="DOI">10.1021/jm701522b</idno>
		<idno type="PMID">18412318</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Medicinal Chemistry</title>
		<title level="j" type="abbrev">J. Med. Chem.</title>
		<idno type="ISSN">0022-2623</idno>
		<idno type="ISSNe">1520-4804</idno>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2758" to="2765" />
			<date type="published" when="2008-05" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Search for α-helical propensity in the receptor-bound conformation of glucagon-like peptide-1</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eunice</forename><forename type="middle">N</forename><surname>Murage</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jonathan</forename><forename type="middle">C</forename><surname>Schroeder</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Martin</forename><surname>Beinborn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jung-Mo</forename><surname>Ahn</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bmc.2008.10.006</idno>
		<idno type="PMID">18952440</idno>
	</analytic>
	<monogr>
		<title level="j">Bioorganic &amp; Medicinal Chemistry</title>
		<title level="j" type="abbrev">Bioorganic &amp; Medicinal Chemistry</title>
		<idno type="ISSN">0968-0896</idno>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">23</biblScope>
			<biblScope unit="page" from="10106" to="10112" />
			<date type="published" when="2008-12" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Conformation of glucagon in a lipid-water interphase by 1H nuclear magnetic resonance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Braun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Wider</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Wüthrich</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0022-2836(83)80143-0</idno>
		<idno type="PMID">6631957</idno>
		<idno type="PII">S0022-2836(83)80143-0</idno>
		<idno type="ark">ark:/67375/6H6-QZ0QX55J-L</idno>
		<idno type="istexId">B41B8B090E4B8706C58B3609B192E479F5AAF6D2</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Biology</title>
		<title level="j" type="abbrev">Journal of Molecular Biology</title>
		<idno type="ISSN">0022-2836</idno>
		<imprint>
			<biblScope unit="volume">169</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="921" to="948" />
			<date type="published" when="1983-10" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Structure of Glucagon-Like Peptide(7-36) Amide in a Dodecylphosphocholine Micelle as Determined by 2D NMR</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kevin</forename><surname>Thornton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><forename type="middle">G</forename><surname>Gorenstein</surname></persName>
		</author>
		<idno type="DOI">10.1021/bi00178a009</idno>
		<idno type="PMID">8142350</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<title level="j" type="abbrev">Biochemistry</title>
		<idno type="ISSN">0006-2960</idno>
		<idno type="ISSNe">1520-4995</idno>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="3532" to="3539" />
			<date type="published" when="1994-03-29" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hiroshi</forename><surname>Inooka</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Ohtaki</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Osamu</forename><surname>Kitahara</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takahisa</forename><surname>Ikegami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Satoshi</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chieko</forename><surname>Kitada</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuhiro</forename><surname>Ogi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Haruo</forename><surname>Onda</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masahiko</forename><surname>Fujino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Masahiro</forename><surname>Shirakawa</surname></persName>
		</author>
		<idno type="DOI">10.1038/84159</idno>
		<idno type="PMID">11175907</idno>
	</analytic>
	<monogr>
		<title level="j">Nature Structural Biology</title>
		<title level="j" type="abbrev">Nat. Struct Biol.</title>
		<idno type="ISSN">1072-8368</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="161" to="165" />
			<date type="published" when="2001-02-01" />
			<publisher>Springer Nature</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Biological Activities of Glucagon-Like Peptide-1 Analogues in Vitro and in Vivo</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Q</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Giguere</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Parisien</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Jeng</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">A</forename><surname>St-Pierre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">L</forename><surname>Brubaker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">B</forename><surname>Wheeler</surname></persName>
		</author>
		<idno type="DOI">10.1021/bi0014498</idno>
		<idno type="PMID">11258897</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<title level="j" type="abbrev">Biochemistry</title>
		<idno type="ISSN">0006-2960</idno>
		<idno type="ISSNe">1520-4995</idno>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2860" to="2869" />
			<date type="published" when="2001-03" />
			<publisher>American Chemical Society (ACS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">The PyMOL Molecular Graphics System</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">L</forename><surname>Delano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">DeLano Scientific LLC</title>
		<imprint>
			<date type="published" when="2002" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
